A detailed history of Ariadne Wealth Management, LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Ariadne Wealth Management, LP holds 4,378 shares of NVO stock, worth $261,060. This represents 0.11% of its overall portfolio holdings.

Number of Shares
4,378
Previous 4,429 1.15%
Holding current value
$261,060
Previous $291 Million 23.5%
% of portfolio
0.11%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$58.08 - $81.05 $2,962 - $4,133
-51 Reduced 1.15%
4,378 $223 Million
Q1 2025

May 12, 2025

SELL
$69.3 - $90.95 $4,781 - $6,275
-69 Reduced 1.53%
4,429 $291 Million
Q4 2024

Feb 11, 2025

BUY
$85.0 - $120.04 $46,835 - $66,142
551 Added 13.96%
4,498 $377 Million
Q3 2024

Nov 08, 2024

BUY
$119.07 - $145.42 $469,969 - $573,972
3,947 New
3,947 $425 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $135B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Ariadne Wealth Management, LP Portfolio

Follow Ariadne Wealth Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ariadne Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Ariadne Wealth Management, LP with notifications on news.